Stock Scorecard



Stock Summary for Profound Medical Corp (PROF) - $7.28 as of 12/20/2024 3:59:16 PM EST

Total Score

11 out of 30

Safety Score

20 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for PROF

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for PROF

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for PROF

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for PROF

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for PROF (20 out of 100)

Stock Price Rating (Max of 10) 4
Historical Stock Price Rating (Max of 10) 7
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 2
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 1
Price to Earnings (Max of 10) 0

Latest News for for PROF

Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares 12/10/2024 2:55:00 PM
Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares - Profound Medical ( NASDAQ:PROF ) 12/6/2024 2:04:00 PM
Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares 12/6/2024 2:04:00 PM
Profound Medical Announces Proposed Public Offering of Common Shares 12/5/2024 9:48:00 PM
Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy 12/2/2024 12:30:00 PM
Profound Medical to Unveil Next TULSA-AI® Module, 'UA Alignment Assistant' 11/26/2024 12:45:00 PM
Profound Medical to Unveil Next TULSA-AI® Module, 'UA Alignment Assistant' - Profound Medical ( NASDAQ:PROF ) 11/26/2024 12:45:00 PM
Profound Medical ( PROF ) Reports Q3 Loss, Lags Revenue Estimates 11/7/2024 11:25:00 PM
Wall Street Analysts Predict a 106.45% Upside in Profound Medical ( PROF ) : Here's What You Should Know 11/6/2024 2:55:00 PM
Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System ( OPPS ) Final Rule for CY2025 11/4/2024 11:55:00 AM

Financial Details for PROF

Company Overview

Ticker PROF
Company Name Profound Medical Corp
Country USA
Description Profound Medical Corp. The company is headquartered in Mississauga, Canada.
Sector Name LIFE SCIENCES
Industry Name SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Most Recent Quarter 9/30/2024
Next Earnings Date 3/5/2025

Stock Price History

Last Day Price 7.28
Price 4 Years Ago 20.56
Last Day Price Updated 12/20/2024 3:59:16 PM EST
Last Day Volume 27,999
Average Daily Volume 83,939
52-Week High 11.42
52-Week Low 6.88
Last Price to 52 Week Low 5.81%

Valuation Measures

Trailing PE N/A
Industry PE 51.82
Sector PE 40.44
5-Year Average PE -8.59
Free Cash Flow Ratio 8.09
Industry Free Cash Flow Ratio 33.29
Sector Free Cash Flow Ratio 27.17
Current Ratio Most Recent Quarter 6.12
Total Cash Per Share 0.90
Book Value Per Share Most Recent Quarter 1.26
Price to Book Ratio 6.98
Industry Price to Book Ratio 5.01
Sector Price to Book Ratio 20.63
Price to Sales Ratio Twelve Trailing Months 24.23
Industry Price to Sales Ratio Twelve Trailing Months 12.43
Sector Price to Sales Ratio Twelve Trailing Months 24.53
Analyst Buy Ratings 6
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 30,028,500
Market Capitalization 218,607,480
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 0.35%
Reported EPS 12 Trailing Months -1.34
Reported EPS Past Year -0.92
Reported EPS Prior Year -1.35
Net Income Twelve Trailing Months -31,391,000
Net Income Past Year -28,569,000
Net Income Prior Year -28,669,000
Quarterly Revenue Growth YOY 63.90%
5-Year Revenue Growth 30.38%
Operating Margin Twelve Trailing Months -3.17

Balance Sheet

Total Cash Most Recent Quarter 27,123,000
Total Cash Past Year 26,213,000
Total Cash Prior Year 46,517,000
Net Cash Position Most Recent Quarter 23,725,000
Net Cash Position Past Year 21,213,000
Long Term Debt Past Year 5,000,000
Long Term Debt Prior Year 6,651,000
Total Debt Most Recent Quarter 3,398,000
Equity to Debt Ratio Past Year 0.86
Equity to Debt Ratio Most Recent Quarter 0.90
Total Stockholder Equity Past Year 31,180,000
Total Stockholder Equity Prior Year 52,004,000
Total Stockholder Equity Most Recent Quarter 31,064,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -24,828,002
Free Cash Flow Per Share Twelve Trailing Months -0.83
Free Cash Flow Past Year -22,297,000
Free Cash Flow Prior Year -25,800,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.18
MACD Signal -0.09
20-Day Bollinger Lower Band 6.74
20-Day Bollinger Middle Band 8.04
20-Day Bollinger Upper Band 9.34
Beta 0.83
RSI 37.36
50-Day SMA 8.33
150-Day SMA 8.91
200-Day SMA 10.66

System

Modified 12/21/2024 9:48:37 AM EST